Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19.

Saved in:
Bibliographic Details
Title: Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19.
Authors: Wigerblad G; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Disease, Bethesda, MD, USA., Warner SA; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA., Ramos-Benitez MJ; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA.; Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, Bethesda, MD, USA.; Ponce Health Science University and Ponce Research Institute, Department of Basic Sciences, School of Medicine, Ponce, Puerto Rico, USA., Kardava L; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Tian X; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Miao R; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Reger R; Laboratory of Transplantation Immunotherapy, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Chakraborty M; Laboratory of Transplantation Immunotherapy, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Wong S; Laboratory of Transplantation Immunotherapy, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Kanthi Y; Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Suffredini AF; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA., Dell'Orso S; Genomic Technology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA., Brooks S; Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA., King C; Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA., Shlobin O; Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA., Nathan SD; Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA., Cohen J; Adventist Healthcare Shady Grove Medical Center, Rockville, MD, USA., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA., Childs RW; Laboratory of Transplantation Immunotherapy, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA.; United States Public Health Service Commissioned Corps, Rockville, MD, USA., Kaplan MJ; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Disease, Bethesda, MD, USA., Chertow DS; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.; United States Public Health Service Commissioned Corps, Rockville, MD, USA., Strich JR; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA.; United States Public Health Service Commissioned Corps, Rockville, MD, USA.
Source: Science advances [Sci Adv] 2023 Jan 04; Vol. 9 (1), pp. eade8272. Date of Electronic Publication: 2023 Jan 04.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2375-2548
DOI:10.1126/sciadv.ade8272